Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 6Unknown 2Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Breast 3Lymphoid 2CNS 2Plasma cell 1Other hematologic neoplasm 1Genitourinary 1Dermatologic 1

Conditions

Multiple Myeloma 495Lymphoma 52Recurrence 50Neoplasms, Plasma Cell 49Immunoglobulin Light-chain Amyloidosis 43Neoplasms 35Lymphoma, Non-Hodgkin 35Leukemia 34Hematologic Neoplasms 32Myelodysplastic Syndromes 28Smoldering Multiple Myeloma 27Leukemia, Myeloid, Acute 26Leukemia, Plasma Cell 23Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Monoclonal Gammopathy of Undetermined Significance 18Hodgkin Disease 18Leukemia, Lymphocytic, Chronic, B-Cell 17Amyloidosis 17Lymphoma, B-Cell 15Breast Neoplasms 14Ovarian Neoplasms 12Paraproteinemias 11Myeloproliferative Disorders 10Colorectal Neoplasms 10Primary Myelofibrosis 9Melanoma 9Lymphoma, Follicular 9Infections 9Prostatic Neoplasms 8Lymphoproliferative Disorders 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Drug-Related Side Effects and Adverse Reactions × Plasma cell × Clear all
NCT03711110 2025-03-21

CARTIER

Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

Phase NA Recruiting
514 enrolled
BreastGastrointestinalLymphoidPlasma cell

Breast Neoplasms, Colonic Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Radiation Injuries, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡